log in
CN
HOME
ABOUT US
PORTFOLIOS
OUR TEAM
NEWS
CONTACT US
COMPANY
PORTFOLIO
INSIGHTS
MEDIA FOCUS
COMPANY
2021
ALL
2026
2025
2024
2023
2022
2021
2020
Michael Zhang on Sector Selection and Realizing Returns | TTGG Ventures at SuperReturn Asia
China's capital markets are recovering, but opportunities are emerging ...
09 29
12 23
Yongan Futures (600927), a Portfolio Company of TTGG, Has Set a Benchmark in the Futures Industry by Getting Listed on the Shanghai Stock Exchange.
2021年12月23日,天堂硅谷管理基金投资企业永安期货股份有限公司(股票简称:永安期货;股票代码:600927)在上海证券交易所主板上市,成为A股第...
Learn more
12 22
TTGG Portfolio Company Estone was Honored as the "Golden Bull Best IPO Case" by China Securities Journal
12月22日,由中国证券报主办的第五届中国股权投资金牛奖评选揭晓,天堂硅谷投资的安徽壹石通材料科技股份有限公司(股票简称:壹石通;股票代码:68873...
Learn more
12 20
Bio-Sincerity(301096), a Portfolio Company of TTGG, was Listed on the Growth Enterprise Market (GEM), Becoming a Benchmark for China's Comprehensive "Pharmaceuticals + Clinical" Integrated CRO Enterpr
2021年12月20日,天堂硅谷管理基金投资企业杭州百诚医药科技股份有限公司(股票简称:百诚医药,股票代码:301096)正式在深圳证券交易所创业板上...
Learn more
12 18
Multiple TTGG Hard Tech Portfolio Companies were Awarded the Zero2IPO 2021 Venture50 Award
12月15日,由清科创业、投资界发起的2021 Venture50终评榜单正式出炉!Venture50自清科创业2006年创办以来,已陪伴中国创业者阔...
Learn more
11 04
TTGG Portfolio Company OriGynMed Has Invested in Zonsun Healthcare, Advancing its Strategic Business Layout in Women's Health
【合作伙伴】天堂硅谷管理基金于2021年10月参与了英姿医疗B+ 轮融资,该企业作为国内女性健康领域的创新平台型企业,其前瞻性的战略布局、创新产品开发...
Learn more
10 24
TTGG Participated in Wyze Biotech's Series A Round of Investment. Wyze Biotech is the Pioneer of Global Spot Universal DNT Immune Cell Therapy
近日,天堂硅谷管理基金A轮投资了中国现货通用型免疫细胞疗法的开创者广东瑞顺生物技术有限公司(简称“瑞顺生物”或“公司”),该公司被评为“2021 中国...
Learn more
1
2
3